TrialCancer medicine2025

Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study.

Sarbajit Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.